4.5 Article

Predictors and Moderators of Treatment Outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I)

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jaac.2010.06.013

关键词

OCD; moderators; predictors; sertraline; cognitive behavioral therapy

资金

  1. National Institute of Mental Health (NIMH) [R01 MH55126, R01 MH55121]
  2. Pfizer Inc
  3. Eli Lilly and Co.
  4. Pfizer
  5. National Alliance for Research on Schizophrenia and Depression
  6. MultiHealth Systems
  7. Guilford Press
  8. Oxford University Press
  9. Solvay
  10. SmithKline Beecham
  11. GlaxoSmithKline
  12. Cephalon
  13. Bristol-Myers Squibb
  14. Forest
  15. Ciba Geigy
  16. Kalo-Duphar
  17. American Psychiatric Association

向作者/读者索取更多资源

Objective: To identify predictors and moderators of outcome in the first Pediatric OCD Treatment Study (POTS I) among youth (N = 112) randomly assigned to sertraline, cognitive behavioral therapy (CBT), both sertraline and CBT (COMB), or a pill placebo. Method: Potential baseline predictors and moderators were identified by literature review. The outcome measure was an adjusted week 12 predicted score for the Children's Yale Brown Obsessive Compulsive Scale (CY-BOCS). Main and interactive effects of treatment condition and each candidate predictor or moderator variable were examined using a general linear model on the adjusted predicted week 12 CY-BOCS scores. Results: Youth with lower obsessive-compulsive disorder (OCD) severity, less OCD-related functional impairment, greater insight, fewer comorbid externalizing symptoms, and lower levels of family accommodation showed greater improvement across treatment conditions than their counterparts after acute POTS treatment. Those with a family history of OCD had more than a sixfold decrease in effect size in CBT monotherapy relative to their counterparts in CBT without a family history of OCD. Conclusions: Greater attention is needed to build optimized intervention strategies for more complex youth with OCD. Youth with a family history of OCD are not likely to benefit from CBT unless offered in combination with an SSRI. Clinical Trials Registration Information Treatment of Obsessive Compulsive Disorder (OCD) in Children, http://www.clinicaltrials.gov, NCT00000384. J. Am. Acad. Child Adolesc. Psychiatry, 2010;49(10):1024-1033.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据